OncoMatch/Clinical Trials/NCT06408116
Predicting Esophageal Cancer Borders Using PET-Imaging
Is NCT06408116 recruiting? Yes, currently enrolling (May 2026). This Phase 2 trial studies Chemotherapy for esophagus cancer, stage i.
Treatment: Chemotherapy — The study examines the diagnostic precision of endosonography, mpMRI and PET/CT in defining tumor boundaries and tumor spread before and after neoadjuvant therapy and definitive surgery.
Check if I qualifyExtracted eligibility criteria
Cancer type
Esophageal Carcinoma
Disease stage
Required: Stage I, II
Prior therapy
Cannot have received: radiation therapy
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify